-
EP1310509
European procedure
Extract from the Register of European Patents
EP About this file: EP1310509
| EP1310509 - Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use [Right-click to bookmark this link] | |||
| Former [2003/20] | novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use | ||
| [2003/35] | Status | No opposition filed within time limit Status updated on 19.06.2009 Database last updated on 22.01.2025 | Most recent event Tooltip | 27.11.2009 | Lapse of the patent in a contracting state | published on 30.12.2009 [2009/53] | Applicant(s) | For all designated states SRI International 333 Ravenswood Avenue Menlo Park, CA 94025 / US | [2008/11] |
| Former [2003/20] | For all designated states Sri International 330 Ravenswood Avenue Menlo Park, CA 94025 / US | Inventor(s) | 01 /
Tanabe, Masato 972 Moreno Palo Alto, CA 94303 / US | 02 /
Peters, Richard H. 365 Springpark Circle San Jose, CA 95136 / US | 03 /
Chao, Wan-Ru 1510 Oriole Avenue Sunnyvale, CA 94087 / US | 04 /
Jong, Ling 681 Endicott Drive Sunnyvale, CA 94087 / US | [2003/20] | Representative(s) | Mallalieu, Catherine Louise, et al D Young & Co LLP 120 Holborn London EC1N 2DY / GB | [N/P] |
| Former [2003/20] | Mallalieu, Catherine Louise, et al D. Young & Co., 21 New Fetter Lane London EC4A 1DA / GB | Application number, filing date | 03000183.8 | 23.12.1998 | [2003/20] | Priority number, date | US19970998877 | 24.12.1997 Original published format: US 998877 | [2003/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1310509 | Date: | 14.05.2003 | Language: | EN | [2003/20] | Type: | A3 Search report | No.: | EP1310509 | Date: | 08.12.2004 | [2004/50] | Type: | B1 Patent specification | No.: | EP1310509 | Date: | 13.08.2008 | Language: | EN | [2008/33] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 27.10.2004 | Classification | IPC: | C07J41/00, A61K31/57, C07J43/00, A61K31/56, A61K31/575, A61K31/58, A61P5/32 | [2004/50] | CPC: |
C07J41/00 (EP,KR,US);
A61P11/00 (EP);
A61P15/02 (EP);
A61P15/04 (EP);
A61P15/08 (EP);
A61P15/12 (EP);
A61P15/14 (EP);
A61P17/00 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P3/06 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P5/32 (EP);
A61P9/12 (EP);
C07J41/0072 (EP,US);
C07J41/0077 (EP,US);
C07J43/003 (EP,US);
A61K9/02 (EP,US)
(-)
|
| Former IPC [2003/20] | C07J41/00, C07J43/00, A61K31/56, A61K31/57, A61K31/575, A61K31/58, A61P5/32 | Designated contracting states | DE, FR, GB, IT, NL [2003/20] | Title | German: | Anti-östrogene Steroide, pharmazeutische Zusammensetzungen und Verwendungen davon | [2003/20] | English: | Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use | [2003/35] | French: | Nouveaux stéroides anti-oestrogènes, compositions pharmaceutiques associées et leur mode d'utilisation | [2003/20] |
| Former [2003/20] | novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use | Examination procedure | 07.01.2003 | Examination requested [2003/20] | 24.01.2006 | Amendment by applicant (claims and/or description) | 08.05.2006 | Despatch of a communication from the examining division (Time limit: M06) | 17.11.2006 | Reply to a communication from the examining division | 22.03.2007 | Despatch of a communication from the examining division (Time limit: M04) | 26.07.2007 | Reply to a communication from the examining division | 18.02.2008 | Communication of intention to grant the patent | 26.06.2008 | Fee for grant paid | 26.06.2008 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP98964882.9 / EP1056768 | Divisional application(s) | EP07015863.9 / EP1847548 | EP10177213.5 / EP2305694 | Opposition(s) | 14.05.2009 | No opposition filed within time limit [2009/30] | Fees paid | Renewal fee | 07.01.2003 | Renewal fee patent year 03 | 07.01.2003 | Renewal fee patent year 04 | 07.01.2003 | Renewal fee patent year 05 | 29.12.2003 | Renewal fee patent year 06 | 23.12.2004 | Renewal fee patent year 07 | 27.12.2005 | Renewal fee patent year 08 | 27.12.2006 | Renewal fee patent year 09 | 24.12.2007 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | GB | 23.12.2008 | [2010/01] | Documents cited: | Search | [A]US3271428 (VILLANI FRANK J) [A] 1-24 * column 2, line 58 - line 68; examples 1,2,5 *; | [A]US3318917 (BENN WALTER R) [A] 1-4,8-24 * page 2, line 29 - line 37; examples 9-14 *; | [A]US3448126 (BENN WALTER R) [A] 1-4,8-24 * column 3, line 38 - line 43; claim 1 *; | [A]DE2361120 (AKZO NV) [A] 1,2,5-7,10-24 * page 4, paragraph 2 - paragraph 3; examples 5,6 *; | [A]EP0471612 (ROUSSEL UCLAF [FR]) [A] 1,2,5-7,10-24 * page 42 - page 43; example 14 * * page 11, line 2 - line 8 *; | [A]EP0546591 (SCHERING AG [DE]) [A] 1,2,5-7,10-24* the whole document, in particular page 2, lines 50-52 *; | [A]WO9313123 (ROUSSEL UCLAF [FR]) [A] 1-24 * the whole document, in particular page 17, paragraph 3-4 and pages 67-68 *; | [A] - POIRIER D ET AL, "D-ring alkylamide derivatives of estradiol: effect on ER-binding affinity and antiestrogenic activity", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (19961105), vol. 6, no. 21, page 2537-2542, XP004135909 [A] 1-24 * the whole document * DOI: http://dx.doi.org/10.1016/0960-894X(96)00472-6 | [A] - PETERS R H ET AL, "17-DESOXY ESTROGEN ANALOGUES", JOURNAL OF MEDICINAL CHEMISTRY, (198907), vol. 32, no. 7, pages 1642 - 1652, XP002005625 [A] 1-24 * page 1646; tables II,III in particular table II, compounds 12,24,36 on page 1646 * DOI: http://dx.doi.org/10.1021/jm00127a040 |